News

The study results demonstrated that Rotarix prevented the disease in 61.2% of these infants. It also showed that Rotarix provided broad protection against diverse circulating rotavirus strains and

Research and development across Atlantic Canada is benefiting from an important federal investment of $62.4m, under Round VII of the Atlantic Innovation Fund (AIF). Reportedly, in the island,

Reportedly, Novella will assume the use of some of OSI’s facilities in Boulder and employ members of OSI’s Boulder staff. OSI had previously announced plans to consolidate its

The company reported that the patient was given a single dose of 1 X 109 viral particles of Ad-VEGF-D and has been moved from post operative critical care

The company’s data supports the notion that the negative feedback of exogenous testosterone administered by any route suppresses the hypothalamic–pituitary axis and hence spermatogenesis. The discussion with the

CAMH has applied for international patent protection for the diagnostic test designed by its scientist, Dr. John Vincent and co-inventors, and being developed by Athena Diagnostics. CAMH said

On 11 January, ReNeuron announced that it finalised and submitted the supplemental pre-clinical data package requested by the UK Gene Therapy Advisory Committee (GTAC), in support of the

Allowed claims cover the method of protecting a mammal from radiation using flagellin or its derivatives, including Protectan CBLB502. The US, nine member countries of the Eurasian Patent

The company said that Livea mimics the body’s natural signaling process making the body feel full, leading to weight loss. As the proprietary blend of ingredients is all-natural,